[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 31 of about 31
1. Mulkeen AL, Yoo PS, Cha C: Less common neoplasms of the pancreas. World J Gastroenterol; 2006 May 28;12(20):3180-5
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Recently, there has been an increased recognition of neoplasms of the pancreas other than ductal adenocarcinoma.
  • Although not as well studied or characterized as pancreatic adenocarcinoma there are many distinct lesions which exhibit diverse biological behaviors and varying degrees of malignancy.
  • These lesions include: endocrine neoplasms, cystic tumors, solid pseudopapillary tumors, acinar cell carcinoma, squamous cell carcinoma, primary lymphoma of the pancreas, and metastatic lesions to the pancreas.
  • This review article discusses the clinical course, diagnosis, and treatment of these less common, but quite relevant, neoplasms of the pancreas.
  • [MeSH-major] Pancreatic Neoplasms / diagnosis. Pancreatic Neoplasms / therapy
  • [MeSH-minor] Adenocarcinoma, Mucinous / diagnosis. Adenocarcinoma, Mucinous / therapy. Carcinoma, Acinar Cell / diagnosis. Carcinoma, Acinar Cell / therapy. Carcinoma, Papillary / diagnosis. Carcinoma, Papillary / therapy. Carcinoma, Squamous Cell / diagnosis. Carcinoma, Squamous Cell / therapy. Cystadenoma, Mucinous / diagnosis. Cystadenoma, Mucinous / therapy. Cystadenoma, Serous / diagnosis. Cystadenoma, Serous / therapy. Endocrine Gland Neoplasms / diagnosis. Endocrine Gland Neoplasms / therapy. Humans. Lymphoma / diagnosis. Lymphoma / therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Pathol. 2002 Apr;160(4):1361-9 [11943721.001]
  • [Cites] Am J Pathol. 2002 Mar;160(3):953-62 [11891193.001]
  • [Cites] Ann Surg Oncol. 2002 Aug;9(7):675-9 [12167582.001]
  • [Cites] N Engl J Med. 2002 Nov 28;347(22):1783-91 [12456855.001]
  • [Cites] J Clin Oncol. 2002 Dec 15;20(24):4673-8 [12488412.001]
  • [Cites] J Clin Gastroenterol. 2003 Mar;36(3):261-5 [12590239.001]
  • [Cites] J Am Coll Surg. 2005 Jun;200(6):965-72 [15922212.001]
  • [Cites] Pancreas. 2005 Aug;31(2):182-7 [16025006.001]
  • [Cites] Ann Surg. 2005 Sep;242(3):413-9; discussion 419-21 [16135927.001]
  • [Cites] J Clin Gastroenterol. 2005 Nov-Dec;39(10):915-9 [16208119.001]
  • [Cites] J Clin Oncol. 2005 Jul 10;23(20):4518-23 [16002842.001]
  • [Cites] Leuk Lymphoma. 2003 Jan;44(1):205-7 [12691166.001]
  • [Cites] Pancreas. 2003 Jul;27(1):e18-22 [12826914.001]
  • [Cites] Arch Surg. 2003 Aug;138(8):859-66 [12912744.001]
  • [Cites] Digestion. 2003;68(1):24-33 [12949436.001]
  • [Cites] J Gastrointest Surg. 2003 Dec;7(8):970-7 [14675706.001]
  • [Cites] Endocr Relat Cancer. 2004 Mar;11(1):1-18 [15027882.001]
  • [Cites] Ann Surg. 2004 Mar;239(3):400-8 [15075659.001]
  • [Cites] Ann Surg. 2004 May;239(5):678-85; discussion 685-7 [15082972.001]
  • [Cites] Ann Surg. 2004 Jun;239(6):788-97; discussion 797-9 [15166958.001]
  • [Cites] J Surg Res. 2004 Jul;120(1):139-61 [15172200.001]
  • [Cites] Am J Clin Pathol. 2004 Jun;121(6):898-903 [15198364.001]
  • [Cites] Virchows Arch. 2004 Jun;444(6):527-35 [15057558.001]
  • [Cites] N Engl J Med. 2004 Sep 16;351(12):1218-26 [15371579.001]
  • [Cites] Cancer. 1980 Sep 1;46(5):1192-6 [7214302.001]
  • [Cites] Surgery. 1990 Sep;108(3):475-80 [2396191.001]
  • [Cites] Cancer. 1991 Sep 15;68(6):1329-34 [1678681.001]
  • [Cites] Ann Surg. 1992 Jan;215(1):8-18 [1531004.001]
  • [Cites] Acta Cytol. 1992 Jul-Aug;36(4):471-6 [1636336.001]
  • [Cites] Medicine (Baltimore). 1996 Mar;75(2):53-63 [8606627.001]
  • [Cites] J Gastrointest Surg. 1998 Sep-Oct;2(5):472-82 [9843608.001]
  • [Cites] Surgery. 1998 Dec;124(6):1050-5 [9854582.001]
  • [Cites] Am J Surg Pathol. 1999 Apr;23(4):410-22 [10199470.001]
  • [Cites] Arch Surg. 1999 Oct;134(10):1131-6 [10522860.001]
  • [Cites] Gastroenterol Clin Biol. 2004 Oct;28(10 Pt 1):872-6 [15523224.001]
  • [Cites] Cancer. 2004 Oct 25;102(5):315-21 [15386314.001]
  • [Cites] AJR Am J Roentgenol. 2005 Feb;184(2):511-9 [15671372.001]
  • [Cites] Am J Surg Pathol. 2005 Apr;29(4):512-9 [15767807.001]
  • [Cites] Pancreas. 2005 Apr;30(3):218-22 [15782097.001]
  • [Cites] Ann Surg Oncol. 2005 Feb;12(2):124-32 [15827792.001]
  • [Cites] Am J Surg. 1999 Oct;178(4):269-74 [10587182.001]
  • [Cites] J Prosthet Dent. 1999 Nov;82(5):512-4 [10559720.001]
  • [Cites] Gastroenterology. 2005 May;128(6):1668-84 [15887158.001]
  • [Cites] J Am Coll Surg. 2000 Apr;190(4):432-45 [10757381.001]
  • [Cites] AJR Am J Roentgenol. 2000 Jul;175(1):99-103 [10882255.001]
  • [Cites] Med Oncol. 2000 Aug;17(3):237-47 [10962538.001]
  • [Cites] Surgery. 2001 Mar;129(3):380-3 [11231470.001]
  • [Cites] Oncology. 2001;60(4):322-9 [11408800.001]
  • [Cites] Front Neuroendocrinol. 2001 Oct;22(4):309-39 [11587555.001]
  • [Cites] Ann Surg Oncol. 2002 Jan-Feb;9(1):35-40 [11833495.001]
  • [Cites] Pancreatology. 2001;1(6):641-7 [12120248.001]
  • (PMID = 16718837.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] China
  • [Number-of-references] 51
  • [Other-IDs] NLM/ PMC4087960
  •  go-up   go-down


2. Ito Y, Miyauchi A: Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid. Endocr J; 2009;56(2):177-92
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Differentiated thyroid carcinoma originates from thyroid follicular cells and is the most prominent malignancy of the endocrine organs.
  • Papillary carcinoma frequently metastasizes to the regional lymph node and shows multicentricity in the thyroid gland.
  • [MeSH-major] Carcinoma, Papillary / diagnosis. Carcinoma, Papillary / therapy. Thyroid Neoplasms / diagnosis. Thyroid Neoplasms / therapy
  • [MeSH-minor] Adenocarcinoma, Follicular / diagnosis. Adenocarcinoma, Follicular / pathology. Humans. Japan / epidemiology. Lymphatic Metastasis / pathology. Prognosis. Thyroidectomy / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18703852.001).
  • [ISSN] 1348-4540
  • [Journal-full-title] Endocrine journal
  • [ISO-abbreviation] Endocr. J.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Japan
  • [Number-of-references] 113
  •  go-up   go-down


3. Pallante P, Visone R, Croce CM, Fusco A: Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas. Endocr Relat Cancer; 2010 Mar;17(1):F91-104
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Carcinoma of the thyroid gland is an uncommon cancer, but one of the most frequent malignancies of the endocrine system.
  • Here, other than summarizing the current findings on microRNA expression in human thyroid carcinomas, we discuss the mechanisms by which microRNA deregulation may play a role in thyroid carcinogenesis, and the possible use of microRNA knowledge in the diagnosis and therapy of thyroid neoplasms.
  • [MeSH-major] Adenocarcinoma, Follicular / genetics. Cell Transformation, Neoplastic / genetics. Gene Expression Regulation, Neoplastic. MicroRNAs / genetics. RNA, Neoplasm / genetics. Thyroid Neoplasms / genetics
  • [MeSH-minor] Animals. Biomarkers, Tumor / analysis. Carcinoma / diagnosis. Carcinoma, Papillary / diagnosis. Diagnosis, Differential. Gene Expression Profiling. Humans. Mice. Mice, Transgenic. Mutation. Neoplasms, Radiation-Induced / diagnosis. Neoplasms, Radiation-Induced / genetics. Neoplasms, Radiation-Induced / pathology. Oligonucleotide Array Sequence Analysis. Oncogenes

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19942715.001).
  • [ISSN] 1479-6821
  • [Journal-full-title] Endocrine-related cancer
  • [ISO-abbreviation] Endocr. Relat. Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / MicroRNAs; 0 / RNA, Neoplasm
  • [Number-of-references] 106
  •  go-up   go-down


Advertisement
4. Saggiorato E, De Pompa R, Volante M, Cappia S, Arecco F, Dei Tos AP, Orlandi F, Papotti M: Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. Endocr Relat Cancer; 2005 Jun;12(2):305-17
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Our data showed that, as compared with the use of single markers, the sequential combination of two markers represents the most accurate immunohistochemical panel in managing patients with a fine-needle aspiration biopsy diagnosis of 'follicular neoplasms', especially in otherwise controversial categories such as oncocytic tumours.
  • [MeSH-major] Adenocarcinoma, Follicular / diagnosis. Biomarkers, Tumor / analysis. Immunohistochemistry. Thyroid Gland / pathology. Thyroid Neoplasms / diagnosis
  • [MeSH-minor] Biopsy, Fine-Needle. Diagnosis, Differential. Humans

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15947105.001).
  • [ISSN] 1351-0088
  • [Journal-full-title] Endocrine-related cancer
  • [ISO-abbreviation] Endocr. Relat. Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


5. Delellis RA: Challenging lesions in the differential diagnosis of endocrine tumors: parathyroid carcinoma. Endocr Pathol; 2008;19(4):221-5
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Challenging lesions in the differential diagnosis of endocrine tumors: parathyroid carcinoma.
  • While the diagnosis of adenomas is usually straightforward, parathyroid carcinomas (PTCAs) often present considerable diagnostic challenges.
  • An unequivocal diagnosis of PTCA should be restricted to those tumors that invade adjacent soft tissues, thyroid gland, blood vessels, or perineural spaces or to those cases with documented metastases.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenoma / diagnosis. Parathyroid Neoplasms / diagnosis
  • [MeSH-minor] Biomarkers, Tumor / analysis. Cell Nucleus / chemistry. Cell Nucleus / pathology. Diagnosis, Differential. Humans. Immunohistochemistry. Mutation. Neoplasm Invasiveness. Tumor Suppressor Proteins / analysis. Tumor Suppressor Proteins / genetics. Tumor Suppressor Proteins / metabolism

  • Genetic Alliance. consumer health - Parathyroid carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Endocrinol (Oxf). 1996 Aug;45(2):195-200 [8881452.001]
  • [Cites] J Clin Endocrinol Metab. 1988 Oct;67(4):779-84 [3417849.001]
  • [Cites] Arch Pathol Lab Med. 2008 Aug;132(8):1251-62 [18684024.001]
  • [Cites] Nat Genet. 2002 Dec;32(4):676-80 [12434154.001]
  • [Cites] Am J Surg Pathol. 1993 Aug;17(8):820-9 [8338192.001]
  • [Cites] Int J Oncol. 2002 Oct;21(4):727-35 [12239610.001]
  • [Cites] World J Surg. 2008 May;32(5):815-21 [18338208.001]
  • [Cites] Endocr Relat Cancer. 2006 Jun;13(2):509-23 [16728578.001]
  • [Cites] N Engl J Med. 1994 Mar 17;330(11):757-61 [7906387.001]
  • [Cites] Am J Surg Pathol. 2006 Sep;30(9):1140-9 [16931959.001]
  • [Cites] Clin Endocrinol (Oxf). 2003 Aug;59(2):180-9 [12864795.001]
  • [Cites] Cancer. 1973 Mar;31(3):600-5 [4693587.001]
  • [Cites] Am J Pathol. 2000 Aug;157(2):579-86 [10934160.001]
  • [Cites] J Pathol. 2004 Jan;202(1):86-94 [14694525.001]
  • [Cites] Adv Anat Pathol. 2008 May;15(3):179; author reply 179-80 [18434772.001]
  • [Cites] Clin Cancer Res. 2004 Oct 1;10(19):6629-37 [15475453.001]
  • [Cites] J Med Genet. 2003 Sep;40(9):657-63 [12960210.001]
  • [Cites] Lancet. 1977 Mar 5;1(8010):549 [65648.001]
  • [Cites] Am J Clin Pathol. 1981 Mar;75(3):345-7 [7211756.001]
  • [Cites] Am J Surg Pathol. 1999 Mar;23(3):288-95 [10078919.001]
  • [Cites] Endocr Relat Cancer. 2007 Jun;14(2):501-12 [17639063.001]
  • [Cites] N Engl J Med. 2003 Oct 30;349(18):1722-9 [14585940.001]
  • [Cites] Hum Pathol. 2003 Jan;34(1):54-64 [12605367.001]
  • [Cites] Eur J Endocrinol. 2007 May;156(5):547-54 [17468190.001]
  • [Cites] Am J Surg Pathol. 2004 May;28(5):578-84 [15105644.001]
  • [Cites] Adv Anat Pathol. 2005 Mar;12(2):53-61 [15731573.001]
  • [Cites] Clin Endocrinol (Oxf). 2004 Jan;60(1):99-106 [14678295.001]
  • [Cites] Hum Pathol. 1995 Feb;26(2):135-8 [7860042.001]
  • [Cites] Surg Gynecol Obstet. 1948 Jan;86(1):1-21 [18932871.001]
  • (PMID = 19058032.001).
  • [ISSN] 1046-3976
  • [Journal-full-title] Endocrine pathology
  • [ISO-abbreviation] Endocr. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / CDC73 protein, human; 0 / Tumor Suppressor Proteins
  • [Number-of-references] 35
  •  go-up   go-down


6. Singh R, Basturk O, Klimstra DS, Zamboni G, Chetty R, Hussain S, La Rosa S, Yilmaz A, Capelli P, Capella C, Cheng JD, Adsay NV: Lipid-rich variant of pancreatic endocrine neoplasms. Am J Surg Pathol; 2006 Feb;30(2):194-200
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lipid-rich variant of pancreatic endocrine neoplasms.
  • Most pancreatic endocrine neoplasms (PENs) show characteristic and well-recognized endocrine morphology; however, a lipid-rich pattern, which can present a diagnostic problem in biopsies, has been reported, mostly as individual cases.
  • In some cases, the nuclei were distorted by the vesicles, and the usual endocrine chromatin pattern was not evident.
  • Pathology reports indicated substantial diagnostic challenge in these cases; on biopsies, 1 case was originally diagnosed as adrenal cortical carcinoma, another as renal cell carcinoma, a third as solid-pseudopapillary tumor, and a fourth had a fine needle aspiration cytologic diagnosis of adenocarcinoma.
  • [MeSH-major] Endocrine Gland Neoplasms / pathology. Lipids. Pancreatic Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma / pathology. Adrenocortical Carcinoma / pathology. Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / analysis. Carcinoma, Renal Cell / pathology. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Male. Microscopy, Electron, Transmission. Middle Aged. Multiple Endocrine Neoplasia Type 1 / pathology. von Hippel-Lindau Disease / complications

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16434893.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Lipids
  •  go-up   go-down


7. Nakano S, Shomura H, Akabane H, Inagaki M, Yanagida N: [Two cases of gastric endocrine cell carcinoma]. Gan To Kagaku Ryoho; 2010 Nov;37(12):2505-7
Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Two cases of gastric endocrine cell carcinoma].
  • Gastric endocrine cell carcinoma is rare and associated with a poor prognosis.
  • The first case was a man in his sixties with gastric endocrine cell carcinoma, of which a clinical finding was T2N1M0H1 (Stage IV).
  • But the tumor was re-grown and the patient died twenty months after diagnosis.
  • The second case was a man in his seventies with gastric endocrine cell carcinoma, of which a clinical finding was T3N1M0H0P0, Stage IIIa, underwent total gastrectomy.
  • [MeSH-major] Endocrine Gland Neoplasms / pathology. Stomach Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma / pathology. Adenocarcinoma / therapy. Aged. Antineoplastic Agents / administration & dosage. Antineoplastic Agents, Phytogenic / administration & dosage. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Camptothecin / administration & dosage. Camptothecin / analogs & derivatives. Cisplatin / administration & dosage. Drug Combinations. Humans. Male. Middle Aged. Oxonic Acid / administration & dosage. Tegafur / administration & dosage

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21224621.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Antineoplastic Agents, Phytogenic; 0 / Drug Combinations; 150863-82-4 / S 1 (combination); 1548R74NSZ / Tegafur; 5VT6420TIG / Oxonic Acid; 7673326042 / irinotecan; Q20Q21Q62J / Cisplatin; XT3Z54Z28A / Camptothecin
  •  go-up   go-down


8. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W, European Thyroid Cancer Taskforce: European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol; 2006 Jun;154(6):787-803
Hazardous Substances Data Bank. THYROGLOBULIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium.

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Eur J Endocrinol. 2006 Aug;155(2):385
  • (PMID = 16728537.001).
  • [ISSN] 0804-4643
  • [Journal-full-title] European journal of endocrinology
  • [ISO-abbreviation] Eur. J. Endocrinol.
  • [Language] ENG
  • [Publication-type] Consensus Development Conference; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Autoantibodies; 0 / Iodine Radioisotopes; 9010-34-8 / Thyroglobulin
  • [Number-of-references] 116
  •  go-up   go-down


9. Marsh WL, Colonna J, Yearsley M, Bloomston M, Frankel WL: Calponin is expressed in serous cystadenomas of the pancreas but not in adenocarcinomas or endocrine tumors. Appl Immunohistochem Mol Morphol; 2009 May;17(3):216-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Calponin is expressed in serous cystadenomas of the pancreas but not in adenocarcinomas or endocrine tumors.
  • The diagnosis of serous microcystic adenoma (SMA) is usually straightforward.
  • For small biopsies and/or unusual variants, the differential diagnosis includes other pancreatic or metastatic neoplasms showing cystic or clear cell features.
  • We evaluated immunostains for potential use in the diagnosis of SMA.
  • Additionally, microarrays previously constructed from 56 pancreatic adenocarcinomas (PACs) and 64 pancreatic endocrine tumors (PENs) were studied.
  • An immunohistochemical profile of staining with calponin, alpha-inhibin, and m-NSE and absent staining with chromogranin supports the diagnosis of SMA, and distinguishes SMA from PAC and PEN.
  • Calponin and alpha-inhibin are the most useful positive markers for SMA, and are negative in most entities in the differential diagnosis.

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19391217.001).
  • [ISSN] 1533-4058
  • [Journal-full-title] Applied immunohistochemistry & molecular morphology : AIMM
  • [ISO-abbreviation] Appl. Immunohistochem. Mol. Morphol.
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Calcium-Binding Proteins; 0 / Microfilament Proteins; 0 / calponin; 0 / inhibin-alpha subunit; 57285-09-3 / Inhibins; EC 4.2.1.11 / Phosphopyruvate Hydratase
  •  go-up   go-down


10. Norimura D, Mizuta Y, Oohara H, Okamoto K, Hayashi H, Matuo T, Nakagoe T, Isomoto H, Shikuwa S, Kohno S: [A case of endocrine carcinoma of the sigmoid colon]. Nihon Shokakibyo Gakkai Zasshi; 2008 Feb;105(2):228-34

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of endocrine carcinoma of the sigmoid colon].
  • We report a case of endocrine carcinoma of the sigmoid colon.
  • He was given a diagnosis of the poorly differentiated adenocarcinoma of the colon, and underwent sigmoidectomy with dissection of the lymph nodes.
  • Histological and immunohistochemical examinations of the resected specimen revealed endocrine carcinoma.
  • Endocrine carcinoma of the colon is rare, and the prognosis is very poor.
  • [MeSH-major] Endocrine Gland Neoplasms / pathology. Sigmoid Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18250594.001).
  • [ISSN] 0446-6586
  • [Journal-full-title] Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
  • [ISO-abbreviation] Nihon Shokakibyo Gakkai Zasshi
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


11. Ishida M, Katsura K, Nagata A, Kijima K, Kushima R, Okabe H: [A case of primary mucinous carcinoma with endocrine differentiation of the skin]. Rinsho Byori; 2008 Jun;56(6):455-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of primary mucinous carcinoma with endocrine differentiation of the skin].
  • Primary mucinous carcinoma of the skin (MCS) is a rare skin appendage tumor and only a few cases of MCS with endocrine differentiation have been reported.
  • Here we report an additional case of primary pure MCS with endocrine differentiation arising in the face.
  • There was no tumor in the other organs and synaptophysin and chromogranin A were sporadically shown immunohistochemically in the tumor cells; a diagnosis of primary pure MCS with endocrine differentiation was made.
  • It is presumed that MCS is derived from the apocrine gland, which is closely related to the mammary gland.
  • Although endocrine differentiation is not uncommon in pure mucinous carcinoma of the breast, there have been only a few reports published on endocrine differentiation in MCS.
  • [MeSH-major] Adenocarcinoma, Mucinous / pathology. Facial Neoplasms / pathology. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18646630.001).
  • [ISSN] 0047-1860
  • [Journal-full-title] Rinsho byori. The Japanese journal of clinical pathology
  • [ISO-abbreviation] Rinsho Byori
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


12. Marrache F, Cazals-Hatem D, Kianmanesh R, Palazzo L, Couvelard A, O'Toole D, Maire F, Hammel P, Levy P, Sauvanet A, Ruszniewski P: Endocrine tumor and intraductal papillary mucinous neoplasm of the pancreas: a fortuitous association? Pancreas; 2005 Jul;31(1):79-83
Hazardous Substances Data Bank. GLUCAGON .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endocrine tumor and intraductal papillary mucinous neoplasm of the pancreas: a fortuitous association?
  • OBJECTIVES: Pancreatic endocrine tumors (PETs) and intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are rare diseases of the pancreas.
  • Cases of association of endocrine and exocrine neoplasms of the pancreas have been reported, corresponding to mixed or amphicrine tumors.
  • RESULTS: Preoperative diagnosis was unspecified pancreatic tumor (n = 1), IPMN (n = 2), and association of PET and IPMN (n = 3).
  • CONCLUSION: This study describes a new aspect of endocrine-exocrine pancreatic neoplasm association.
  • [MeSH-major] Adenocarcinoma, Mucinous / pathology. Carcinoma, Pancreatic Ductal / pathology. Carcinoma, Papillary / pathology. Endocrine Gland Neoplasms / pathology. Pancreatic Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15968252.001).
  • [ISSN] 1536-4828
  • [Journal-full-title] Pancreas
  • [ISO-abbreviation] Pancreas
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Chromogranin A; 0 / Chromogranins; 9007-92-5 / Glucagon
  •  go-up   go-down


13. Balcerzak W, Bednarz W, Domosławski P, Olewiński R, Kolesińska J, Kaminski Z, Dziarkowska K, Wieczorek P: [Preliminary approach towards construction of peptide libraries as potential tools for diagnosis of malignant thyroid tumors]. Endokrynol Pol; 2006 Jul-Aug;57(4):307-13
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Preliminary approach towards construction of peptide libraries as potential tools for diagnosis of malignant thyroid tumors].
  • INTRODUCTION: Cancer of thyroid gland is the most common malignancy of the endocrine system.
  • The treatment improvement could be achieved by early diagnosis.
  • [MeSH-major] Adenocarcinoma, Follicular / pathology. Adenoma, Oxyphilic / pathology. Biomarkers, Tumor / analysis. Carcinoma, Papillary, Follicular / pathology. Peptide Library. Thyroid Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17006829.001).
  • [ISSN] 0423-104X
  • [Journal-full-title] Endokrynologia Polska
  • [ISO-abbreviation] Endokrynol Pol
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Poland
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Galectin 3; 0 / Peptide Library; EC 1.11.1.8 / Iodide Peroxidase
  •  go-up   go-down


14. Lange D, Sporny S, Sygut J, Kulig A, Jarzab M, Kula D, Jarzab B: [Histopathological diagnosis of thyroid cancer in a multicenter trial]. Endokrynol Pol; 2006 Jul-Aug;57(4):336-42
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Histopathological diagnosis of thyroid cancer in a multicenter trial].
  • The studies were sent from centres which agreed to participate in the project and than coded in the independent centre--Department of Nuclear Medicine and Endocrine Oncology.
  • The reference diagnosis was made by an agreement between four expert pathologists (D.L., S.S., J.S. and A.K.).
  • Concerning the diagnosis of cancer histotype, the difference between participants diagnosis and the reference one was even higher.
  • The best concordance was achieved in the diagnosis of papillary thyroid cancer, however, on the cost of cancer overdiagnosis by some participants.
  • CONCLUSION: The study documents a high inter-observer variability of thyroid cancer diagnosis and confirms the lesser accuracy of diagnosis of follicular cancer.
  • [MeSH-major] Adenocarcinoma, Follicular / pathology. Adenoma / pathology. Carcinoma, Papillary / pathology. Goiter, Nodular / pathology. Thyroid Neoplasms / pathology
  • [MeSH-minor] Diagnosis, Differential. Histological Techniques / methods. Histological Techniques / standards. Humans. Multicenter Studies as Topic / statistics & numerical data. Observer Variation. Thyroid Gland

  • Genetic Alliance. consumer health - Thyroid Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17006833.001).
  • [ISSN] 0423-104X
  • [Journal-full-title] Endokrynologia Polska
  • [ISO-abbreviation] Endokrynol Pol
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


15. Albores-Saavedra J, Wu J: The many faces and mimics of papillary thyroid carcinoma. Endocr Pathol; 2006;17(1):1-18
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This article provides an overview of the 15 histologic variants of papillary thyroid carcinoma listed by the 2004 World Health Organization (WHO) monograph on endocrine tumors.
  • The histologic features, differential diagnosis, and clinical course of each variant are discussed in some detail.
  • [MeSH-major] Adenocarcinoma, Papillary / pathology. Thyroid Neoplasms / pathology
  • [MeSH-minor] Adenoma / diagnosis. Cell Nucleus / pathology. Diagnosis, Differential. Hashimoto Disease / diagnosis. Humans. Hyperplasia / diagnosis. Thyroid Gland / pathology. World Health Organization

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lab Invest. 1960 Jan-Feb;9:86-97 [14400378.001]
  • [Cites] Mod Pathol. 2000 Jul;13(7):742-6 [10912933.001]
  • [Cites] Am J Surg Pathol. 1995 Jul;19(7):810-4 [7793479.001]
  • [Cites] Am J Clin Pathol. 1988 Feb;89(2):264-7 [3341287.001]
  • [Cites] Virchows Arch. 1996 Nov;429(4-5):213-9 [8972756.001]
  • [Cites] Am J Clin Pathol. 2002 Jan;117(1):19-21 [11789725.001]
  • [Cites] Am J Surg Pathol. 2004 Oct;28(10):1336-40 [15371949.001]
  • [Cites] Hum Pathol. 2005 Jun;36(6):694-7 [16021577.001]
  • [Cites] Appl Immunohistochem Mol Morphol. 2002 Dec;10(4):332-8 [12613443.001]
  • [Cites] Am J Clin Pathol. 1986 Jan;85(1):77-80 [3940424.001]
  • [Cites] Hum Pathol. 1995 Oct;26(10):1099-108 [7557943.001]
  • [Cites] Oncogene. 2003 Jul 17;22(29):4578-80 [12881714.001]
  • [Cites] Pathol Int. 2002 Jan;52(1):54-8 [11940207.001]
  • [Cites] Hum Pathol. 1990 Nov;21(11):1151-5 [2227923.001]
  • [Cites] Histopathology. 1994 Dec;25(6):549-61 [7698732.001]
  • [Cites] Cancer. 1971 Sep;28(3):763-74 [5096937.001]
  • [Cites] Ann Diagn Pathol. 2003 Dec;7(6):348-53 [15018117.001]
  • [Cites] World J Surg. 1998 Jul;22(7):738-42; discussion 743 [9606291.001]
  • [Cites] Cancer. 1997 Sep 15;80(6):1110-6 [9305712.001]
  • [Cites] Diagn Cytopathol. 1998 Feb;18(2):93-7 [9484636.001]
  • [Cites] Am J Surg Pathol. 1988 Jan;12(1):22-7 [3337337.001]
  • [Cites] Cancer. 1994 Jan 15;73(2):416-23 [8293409.001]
  • [Cites] Hum Pathol. 1994 Feb;25(2):192-7 [8119720.001]
  • [Cites] Mod Pathol. 1999 Apr;12(4):400-11 [10229505.001]
  • [Cites] Virchows Arch. 1997 May;430(5):397-405 [9174630.001]
  • [Cites] Cancer. 1998 Feb 15;82(4):740-53 [9477108.001]
  • [Cites] Endocr Pathol. 1997 Winter;8(4):283-292 [12114789.001]
  • [Cites] Am J Clin Pathol. 2001 Nov;116(5):696-702 [11710686.001]
  • [Cites] Anticancer Res. 1998 Jul-Aug;18(4A):2637-41 [9703921.001]
  • [Cites] Am Surg. 1998 Apr;64(4):307-11 [9544139.001]
  • [Cites] J Clin Endocrinol Metab. 2000 Feb;85(2):878-82 [10690905.001]
  • [Cites] Mod Pathol. 1995 May;8(4):366-70 [7567932.001]
  • [Cites] Cleve Clin Q. 1976 WINTER;43(4):207-15 [1000814.001]
  • [Cites] Cancer. 1990 Mar 1;65(5):1173-9 [2302665.001]
  • [Cites] Am J Surg Pathol. 1989 Dec;13(12):1041-9 [2490923.001]
  • [Cites] Am J Surg Pathol. 1996 Aug;20(8):964-74 [8712296.001]
  • [Cites] Cancer. 2003 Jul 1;98(1):31-40 [12833452.001]
  • [Cites] Cancer Res. 2003 Apr 1;63(7):1454-7 [12670889.001]
  • [Cites] Mod Pathol. 2005 Jan;18(1):48-57 [15272279.001]
  • [Cites] Am J Surg Pathol. 1995 Oct;19(10):1209-15 [7573680.001]
  • [Cites] Semin Diagn Pathol. 1985 May;2(2):90-100 [3843693.001]
  • [Cites] J Clin Endocrinol Metab. 1948 Sep;8(9):749-61 [18880943.001]
  • [Cites] Am J Surg Pathol. 1985 Oct;9(10):705-22 [4061729.001]
  • [Cites] Endocr Pathol. 2002 Winter;13(4):301-11 [12665648.001]
  • [Cites] Hum Pathol. 1997 Jan;28(1):47-53 [9013831.001]
  • [Cites] Histopathology. 2004 Nov;45(5):493-500 [15500653.001]
  • [Cites] Am J Surg Pathol. 1984 Mar;8(3):187-92 [6703194.001]
  • [Cites] Am J Surg Pathol. 2001 Dec;25(12):1485-92 [11717537.001]
  • [Cites] Histopathology. 2002 Oct;41(4):357-62 [12383219.001]
  • [Cites] Am J Surg Pathol. 1977 Jun;1(2):123-30 [602974.001]
  • [Cites] Endocr Pathol. 2004 Winter;15(4):297-305 [15681853.001]
  • [Cites] Am J Surg Pathol. 2001 Dec;25(12):1478-84 [11717536.001]
  • [Cites] J Natl Cancer Inst. 2003 Apr 16;95(8):625-7 [12697856.001]
  • [Cites] Virchows Arch. 2002 Apr;440(4):418-24 [11956824.001]
  • [Cites] Pathol Int. 1996 Dec;46(12):939-46 [9110345.001]
  • [Cites] Hum Pathol. 1991 Dec;22(12):1195-205 [1748427.001]
  • [Cites] Arch Pathol Lab Med. 1996 Apr;120(4):397-8 [8619755.001]
  • [Cites] Int J Surg Pathol. 2003 Oct;11(4):249-51 [14615819.001]
  • [Cites] Am J Surg Pathol. 1986 Oct;10(10):672-9 [3766846.001]
  • [Cites] Laryngoscope. 1997 Jan;107(1):95-100 [9001272.001]
  • [Cites] Acta Pathol Jpn. 1993 Jul-Aug;43(7-8):428-33 [8372687.001]
  • [Cites] Am J Surg Pathol. 1983 Dec;7(8):797-807 [6660352.001]
  • [Cites] Cancer. 1966 Aug;19(8):1039-52 [5916581.001]
  • (PMID = 16760576.001).
  • [ISSN] 1046-3976
  • [Journal-full-title] Endocrine pathology
  • [ISO-abbreviation] Endocr. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 68
  •  go-up   go-down


16. Lepage C, Bouvier AM, Manfredi S, Dancourt V, Faivre J: Incidence and management of primary malignant small bowel cancers: a well-defined French population study. Am J Gastroenterol; 2006 Dec;101(12):2826-32
MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Treatment and stage at diagnosis were investigated.
  • There were four main histological types: adenocarcinoma (40.4%), malignant endocrine tumors (30.5%), lymphoma (20.1%), and sarcoma (9.0%).
  • It varied between 56.8% for endocrine tumors and 17.8% for sarcoma.
  • In the multivariate analysis, age, histology, and stage at diagnosis significantly influenced the prognosis.
  • [MeSH-major] Adenocarcinoma / epidemiology. Endocrine Gland Neoplasms / epidemiology. Intestinal Neoplasms / epidemiology. Intestine, Small. Lymphoma / epidemiology. Sarcoma / epidemiology

  • MedlinePlus Health Information. consumer health - Lymphoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17026561.001).
  • [ISSN] 0002-9270
  • [Journal-full-title] The American journal of gastroenterology
  • [ISO-abbreviation] Am. J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


17. Enomoto K, Sakurai K, Amano S: [Experience of parathyroid cancer which required a differentiation from adenoma]. Gan To Kagaku Ryoho; 2010 Nov;37(12):2325-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We noted a thyroid gland mass by examination and referred for a further checkup.
  • The cervical echography evidence showed a mass image of the border regular in the back of inferior pole of left thyroid gland.
  • It also revealed a mass image with the calcification in the inferior pole of left lobe of thyroid gland at the same time.
  • We performed aspiration biopsy cytology for a thyroid gland mass, and it was class IIIa.
  • We also performed parathyroidectomy and left lobe of thyroid gland ablative surgery because of a diagnosis of the hyperparathyroidism confirmed a primary parathyroid adenoma.
  • Preoperative pathological diagnosis was adenoma.
  • However, histopathology laboratory findings showed it to be of adenocarcinoma of the parathyroid, which metastasized into the thyroid.
  • Many times parathyroid cancer preoperative diagnosis is inconclusive.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenoma / diagnosis. Parathyroid Neoplasms / diagnosis
  • [MeSH-minor] Aged. Diagnosis, Differential. Humans. Hyperparathyroidism / etiology. Hyperparathyroidism / surgery. Male. Parathyroidectomy. Thyroid Neoplasms / secondary. Thyroidectomy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21224561.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


18. Vanbeckevoort D: Solid pancreatic masses: benign or malignant. JBR-BTR; 2007 Nov-Dec;90(6):487-9
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Endocrine tumours represent only a minority of those tumours.
  • While endocrine tumours tend to exhibit symptoms earlier in the course of the disease (due to tumour-related hormone production), adenocarcinomas present in nearly all cases in advanced stages when curative resection is not feasible.
  • [MeSH-major] Adenocarcinoma / diagnosis. Endocrine Gland Neoplasms / diagnosis. Magnetic Resonance Imaging / methods. Pancreatic Neoplasms / diagnosis. Tomography, X-Ray Computed / methods
  • [MeSH-minor] Diagnosis, Differential. Humans

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18376761.001).
  • [ISSN] 0302-7430
  • [Journal-full-title] JBR-BTR : organe de la Société royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR)
  • [ISO-abbreviation] JBR-BTR
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Belgium
  • [Number-of-references] 13
  •  go-up   go-down


19. Tison C, Regenet N, Meurette G, Mirallié E, Cassagnau E, Frampas E, Le Borgne J: Cystic dystrophy of the duodenal wall developing in heterotopic pancreas: report of 9 cases. Pancreas; 2007 Jan;34(1):152-6
MedlinePlus Health Information. consumer health - Small Intestine Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pathological findings in surgical specimens were multiple cysts located in the thickened duodenal wall (n = 9), ectopic pancreatic tissue (n = 7), fibrosis of the normal gland (n = 4), and adenocarcinoma in ectopic tissue (n = 1).
  • In 1 case, the patient died of disseminated adenocarcinoma.
  • CONCLUSION: Endoscopic ultrasonography and magnetic resonance pancreatography are the most useful investigations for the diagnosis of CDHP.
  • [MeSH-minor] Adenocarcinoma / complications. Adult. Aged. Cholangiopancreatography, Magnetic Resonance. Female. Follow-Up Studies. Humans. Intestinal Obstruction / radiography. Intestinal Obstruction / surgery. Intestinal Obstruction / ultrasonography. Male. Middle Aged. Pancreatic Neoplasms / complications. Pancreaticoduodenectomy. Pancreatitis, Alcoholic / complications. Retrospective Studies. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17198198.001).
  • [ISSN] 1536-4828
  • [Journal-full-title] Pancreas
  • [ISO-abbreviation] Pancreas
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


20. Adolfsson J, Garmo H, Varenhorst E, Ahlgren G, Ahlstrand C, Andrén O, Bill-Axelson A, Bratt O, Damber JE, Hellström K, Hellström M, Holmberg E, Holmberg L, Hugosson J, Johansson JE, Petterson B, Törnblom M, Widmark A, Stattin P: Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005. Scand J Urol Nephrol; 2007;41(6):456-77
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: The incidence of prostate cancer is rising rapidly in Sweden and there is a need to better understand the pattern of diagnosis, tumor characteristics and treatment.
  • MATERIAL AND METHODS: Between 1996 and 2005, all new cases of adenocarcinoma of the prostate gland were intended to be registered in the National Prostate Cancer Register (NPCR).
  • This register contains information on diagnosing unit, date of diagnosis, cause of diagnosis, tumor grade, tumor stage according to the TNM classification in force, serum prostate-specific antigen (PSA) levels at diagnosis and primary treatment given within the first 6 months after diagnosis.
  • During the study period there was a considerable decrease in median age at the time of diagnosis, a stage migration towards smaller tumors, a decrease in median serum PSA values at diagnosis, a decrease in the age-standardized incidence rate of men diagnosed with distant metastases or with a PSA level of > 100 ng/ml at diagnosis and an increase in the proportion of tumors with Gleason score <6.
  • Relatively large geographical differences in the median age at diagnosis and the age-standardized incidence of cases with category T1c tumors were observed.
  • In men with localized tumors and a PSA level of <20 ng/ml at diagnosis, expectant treatment was more commonly used in those aged > or =75 years than in those aged <75 years.
  • Also, the pattern of endocrine treatment varied in different parts of Sweden.
  • The patterns of diagnosis and treatment of prostate cancer vary considerably in different parts of Sweden.
  • The NPCR continues to be an important source for research, epidemiological surveillance of the incidence, diagnosis and treatment of prostate cancer.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenocarcinoma / therapy. Prostatic Neoplasms / diagnosis. Prostatic Neoplasms / therapy

  • Genetic Alliance. consumer health - Prostate cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17934985.001).
  • [ISSN] 0036-5599
  • [Journal-full-title] Scandinavian journal of urology and nephrology
  • [ISO-abbreviation] Scand. J. Urol. Nephrol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Sweden
  • [Chemical-registry-number] EC 3.4.21.77 / Prostate-Specific Antigen
  •  go-up   go-down


21. Mhanna T, Ranchere-Vince D, Hervieu V, Tardieu D, Scoazec JY, Partensky C: Clear cell myomelanocytic tumor (PEComa) of the duodenum in a child with a history of neuroblastoma. Arch Pathol Lab Med; 2005 Nov;129(11):1484-6
MedlinePlus Health Information. consumer health - Neuroblastoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The diagnosis was obtained by examination of a biopsy specimen taken during laparoscopy.
  • Examination of the surgical specimen confirmed the diagnosis of PEComa.
  • [MeSH-minor] Adenocarcinoma / diagnosis. Biomarkers, Tumor / analysis. Child. Diagnosis, Differential. Endocrine Gland Neoplasms / diagnosis. Humans. Male. Neoplasms, Second Primary. Pancreaticoduodenectomy. Sarcoma, Clear Cell / diagnosis. Treatment Outcome

  • Genetic Alliance. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Intestinal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16253032.001).
  • [ISSN] 1543-2165
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


22. Hutchinson CB, Canlas K, Evans JA, Obando JV, Waugh M: Endoscopic ultrasound-guided fine needle aspiration biopsy of the intrapancreatic accessory spleen: a report of 2 cases. Acta Cytol; 2010 May-Jun;54(3):337-40
MedlinePlus Health Information. consumer health - Pancreatic Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Definitive tissue diagnosis in these 2 cases avoided not only unnecessary surgical intervention but also the need for consideration of a "watch and wait" strategy with further imaging and possible additional biopsy attempts.
  • [MeSH-major] Choristoma / diagnosis. Pancreatic Diseases / diagnosis. Spleen
  • [MeSH-minor] Adenocarcinoma / diagnosis. Antigens, CD / metabolism. Biomarkers / metabolism. Biopsy, Fine-Needle. Diagnosis, Differential. Endocrine Gland Neoplasms / diagnosis. Endosonography. Female. Humans. Male. Middle Aged. Pancreatic Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20518423.001).
  • [ISSN] 0001-5547
  • [Journal-full-title] Acta cytologica
  • [ISO-abbreviation] Acta Cytol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Biomarkers
  •  go-up   go-down


23. Kocjan G: Fine needle aspiration cytology of the pancreas: a guide to the diagnostic approach. Coll Antropol; 2010 Jun;34(2):749-56
MedlinePlus Health Information. consumer health - Pancreatic Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Despite the advances in the imaging techniques, management options for patients are limited and a malignant diagnosis of solid lesions still carries a high mortality rate.
  • The importance of a cytopathologist in preoperative diagnosis, as a member of the multidisciplinary team, is exemplified in the management of patients with neoplastic cysts.
  • A cytological diagnosis can be obtained with minimally invasive techniques that utilize CT US or EUS.
  • [MeSH-minor] Adenocarcinoma / pathology. Cystadenoma / pathology. Endocrine Gland Neoplasms / pathology. Humans. Teratoma / pathology

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20698166.001).
  • [ISSN] 0350-6134
  • [Journal-full-title] Collegium antropologicum
  • [ISO-abbreviation] Coll Antropol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Croatia
  • [Number-of-references] 62
  •  go-up   go-down


24. Kimura N, Kimura I: Podoplanin as a marker for mesothelioma. Pathol Int; 2005 Feb;55(2):83-6
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The utility of podoplanin for the histological diagnosis of tumors was then investigated, especially for mesothelioma.
  • Immunohistochemical study of podoplanin was carried out in five malignant mesotheliomas and 118 other tumors including 93 adenocarcinomas, four squamous cell carcinomas, six gastrointestinal stromal tumors and five endocrine tumors.
  • Among the many antibodies used for differential diagnosis of malignant mesothelioma, podoplanin has the potential to be an excellent tumor marker in both specificity and sensitivity.
  • [MeSH-minor] Adenocarcinoma / diagnosis. Adrenal Gland Neoplasms / diagnosis. Carcinoid Tumor / diagnosis. Carcinoma, Squamous Cell / diagnosis. Diagnosis, Differential. Female. Gastrointestinal Stromal Tumors / diagnosis. Humans. Pheochromocytoma / diagnosis

  • MedlinePlus Health Information. consumer health - Mesothelioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15693854.001).
  • [ISSN] 1320-5463
  • [Journal-full-title] Pathology international
  • [ISO-abbreviation] Pathol. Int.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Membrane Glycoproteins; 0 / PDPN protein, human
  •  go-up   go-down


25. Sebag F, Calzolari F, Harding J, Sierra M, Palazzo FF, Henry JF: Isolated adrenal metastasis: the role of laparoscopic surgery. World J Surg; 2006 May;30(5):888-92
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Primary tumours included lung cancer (n = 9), melanoma (n = 3), mesothelioma (n = 1), rhabdomyosarcoma (n = 1), colonic adenocarcinoma (n = 1) and renal cell carcinoma (n = 1).
  • Pathology confirmed the diagnosis of AM.
  • [MeSH-major] Adrenal Gland Neoplasms / secondary. Adrenal Gland Neoplasms / surgery. Adrenalectomy / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] World J Surg. 2002 Aug;26(8):1043-7 [12045859.001]
  • [Cites] Adv Surg. 2000;34:351-81 [10997228.001]
  • [Cites] Ann Thorac Surg. 2004 Jul;78(1):238-44 [15223436.001]
  • [Cites] Cancer. 1998 Jan 15;82(2):389-94 [9445197.001]
  • [Cites] Cancer J. 2005 Jan-Feb;11(1):64-72 [15831226.001]
  • [Cites] J Laparoendosc Adv Surg Tech A. 2004 Jun;14(3):139-45 [15245665.001]
  • [Cites] Ann Surg Oncol. 1999 Oct-Nov;6(7):633-9 [10560847.001]
  • [Cites] Surgery. 2004 Dec;136(6):1289-96 [15657589.001]
  • [Cites] Clin Endocrinol (Oxf). 2002 Jan;56(1):95-101 [11849252.001]
  • [Cites] Surgery. 1997 Dec;122(6):1132-6 [9426429.001]
  • [Cites] Br J Surg. 1999 May;86(5):656-60 [10361189.001]
  • [Cites] J Thorac Cardiovasc Surg. 2005 Jul;130(1):136-40 [15999053.001]
  • [Cites] Ann Surg Oncol. 2003 Dec;10(10):1191-6 [14654476.001]
  • [Cites] Best Pract Res Clin Endocrinol Metab. 2001 Jun;15(2):149-60 [11472031.001]
  • [Cites] Int J Oncol. 2000 Jul;17(1):181-7 [10853037.001]
  • [Cites] Surg Clin North Am. 2004 Jun;84(3):755-74 [15145233.001]
  • [Cites] Am J Surg. 1999 Jul;178(1):50-3; discussion 54 [10456703.001]
  • [Cites] Surgery. 1991 Feb;109 (2):127-31 [1992544.001]
  • [Cites] Arch Surg. 2002 Aug;137(8):948-51; discussion 952-3 [12146996.001]
  • [Cites] Lancet. 2002 Jun 29;359(9325):2224-9 [12103285.001]
  • [Cites] Ann Thorac Surg. 1996 Dec;62(6):1614-6 [8957360.001]
  • [Cites] Br J Surg. 2005 Jun;92(6):719-23 [15856491.001]
  • [Cites] Br J Surg. 1996 Apr;83(4):528-31 [8665251.001]
  • [Cites] Br J Surg. 2004 Oct;91(10):1259-74 [15376201.001]
  • [Cites] Eur J Cardiothorac Surg. 2004 Jun;25(6):1107-13 [15145017.001]
  • [Cites] Surg Laparosc Endosc Percutan Tech. 2003 Oct;13(5):328-33 [14571170.001]
  • [Cites] World J Surg. 2004 Nov;28(11):1176-9 [15490056.001]
  • [Cites] Ann Thorac Surg. 2001 Mar;71(3):981-5 [11269485.001]
  • [Cites] Ann Surg Oncol. 2002 Jun;9(5):480-5 [12052760.001]
  • (PMID = 16547618.001).
  • [ISSN] 0364-2313
  • [Journal-full-title] World journal of surgery
  • [ISO-abbreviation] World J Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


26. Capezzone M, Morabito E, Bellitti P, Giannasio P, de Santis D, Bruno R: Ectopic intrathyroidal nonfunctioning parathyroid cyst. Endocr Pract; 2007 Jan-Feb;13(1):56-8
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Measurement of parathyroid hormone in the FNAB fluid showed a high concentration, suggestive of the diagnosis of PC.
  • Histologic examination confirmed the diagnosis of intrathyroidal PC, and a papillary microcarcinoma (6 mm in diameter) was found in the right lobe of the thyroid.
  • [MeSH-major] Adenocarcinoma, Papillary / complications. Adenocarcinoma, Papillary / ultrasonography. Cysts / pathology. Parathyroid Diseases / complications. Thyroid Gland / pathology. Thyroid Neoplasms / complications. Thyroid Neoplasms / ultrasonography. Thyroid Nodule / complications. Thyroid Nodule / ultrasonography

  • MedlinePlus Health Information. consumer health - Parathyroid Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17360302.001).
  • [ISSN] 1934-2403
  • [Journal-full-title] Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
  • [ISO-abbreviation] Endocr Pract
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


27. Enomoto K, Sakurai K, Amano S, Shiono M: [A case of malignant lymphoma that seemed to be thyroid cancer lymph nodes recurrence]. Gan To Kagaku Ryoho; 2008 Nov;35(12):2213-5
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A tumor in the survival thyroid gland was confirmed in 1995.
  • In February 2007, the tumor of the survival thyroid gland was enlarged.
  • Histopathology diagnosis showed it to be of a papillary adenocarcinoma of thyroid recurrence.
  • The diagnosis was malignant lymphoma.

  • Genetic Alliance. consumer health - Thyroid Cancer.
  • Genetic Alliance. consumer health - Thyroid Lymphoma.
  • MedlinePlus Health Information. consumer health - Lymphoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19106574.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


28. Lo WK, vansonnenberg E, Shankar S, Morrison PR, Silverman SG, Tuncali K, Rabin M: Percutaneous CT-guided radiofrequency ablation of symptomatic bilateral adrenal metastases in a single session. J Vasc Interv Radiol; 2006 Jan;17(1):175-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the present case, a 71-year-old man with a diagnosis of lung cancer and painful bilateral metastases to the adrenal glands underwent percutaneous CT-guided RF thermal ablation of both adrenal masses in a single session (left adrenal mass, 4.7 cm; right adrenal mass, 4.3 cm), without occurrence of blood pressure instability or other acute complications.
  • Measurement of plasma levels of cortisol, adrenocorticotropic hormone (ACTH), and glucose before and after RF ablation revealed transient changes that suggested preservation of endocrine feedback mechanisms.
  • On further follow-up at 6 months, the patient noted a lack of endocrine sequelae and continued pain relief.
  • [MeSH-major] Adenocarcinoma / surgery. Adrenal Gland Neoplasms / surgery. Catheter Ablation

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16415149.001).
  • [ISSN] 1051-0443
  • [Journal-full-title] Journal of vascular and interventional radiology : JVIR
  • [ISO-abbreviation] J Vasc Interv Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


29. Nijs E, Callahan MJ, Taylor GA: Disorders of the pediatric pancreas: imaging features. Pediatr Radiol; 2005 Apr;35(4):358-73; quiz 457
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Familiarity with the range of normal appearance and the diseases that commonly affect this gland is important for the accurate and timely diagnosis of pancreatic disorders in the pediatric population.
  • Primary pancreatic neoplasms are rare in children and are divided into exocrine tumors such as pancreatoblastoma and adenocarcinoma and into endocrine or islet cell tumors.
  • [MeSH-major] Diagnostic Imaging. Pancreatic Diseases / diagnosis
  • [MeSH-minor] Adult. Child. Humans. Infant. Pancreas / abnormalities. Pancreas / anatomy & histology. Pancreatic Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Diagnostic Imaging.
  • MedlinePlus Health Information. consumer health - Pancreatic Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Radiology. 1986 Mar;158(3):629-31 [3511500.001]
  • [Cites] Pediatr Radiol. 1985;15(5):348-9 [3897999.001]
  • [Cites] Pediatr Radiol. 2001 Feb;31(2):92-7 [11214693.001]
  • [Cites] Pediatr Radiol. 1990;20(5):323-5 [2190152.001]
  • [Cites] J Comput Assist Tomogr. 1993 May-Jun;17 (3):474-6 [8491914.001]
  • [Cites] Eur Radiol. 1998;8(7):1236-44 [9724445.001]
  • [Cites] Pediatr Surg Int. 2001 Nov;17(8):614-20 [11727051.001]
  • [Cites] Pediatr Surg Int. 1998 Jul;13(5-6):428-30 [9639636.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 1996 Dec;23 (5):599-603 [8985852.001]
  • [Cites] J Ultrasound Med. 2000 Nov;19(11):757-63 [11065264.001]
  • [Cites] AJR Am J Roentgenol. 1991 Apr;156(4):799-800 [2003448.001]
  • [Cites] Pediatr Radiol. 1989;19(4):242-5 [2748231.001]
  • [Cites] Pediatr Surg Int. 2002 Mar;18(2-3):190-2 [11956796.001]
  • [Cites] Dig Dis Sci. 1987 Oct;32(10):1075-81 [3308373.001]
  • [Cites] AJR Am J Roentgenol. 1983 Oct;141(4):653-5 [6604410.001]
  • [Cites] Curr Opin Pediatr. 2001 Oct;13(5):447-51 [11801891.001]
  • [Cites] Pediatr Radiol. 2001 Jul;31(7):501-6 [11486805.001]
  • [Cites] Radiology. 1988 Feb;166(2):413-6 [3336716.001]
  • [Cites] J Pediatr Surg. 1995 May;30(5):724-6 [7623239.001]
  • [Cites] J Pediatr Surg. 1993 Dec;28(12):1570-1 [8301494.001]
  • [Cites] Radiology. 1979 Nov;133(2):289-95 [573913.001]
  • [Cites] Abdom Imaging. 2001 Nov-Dec;26(6):648-50 [11907732.001]
  • [Cites] Pediatr Radiol. 1995;25(5):356-9 [7567263.001]
  • [Cites] Gastrointest Radiol. 1987;12 (1):18-22 [3792751.001]
  • [Cites] Radiology. 1996 Mar;198(3):875-9 [8628886.001]
  • [Cites] Radiology. 1987 Aug;164(2):479-81 [3602389.001]
  • [Cites] Radiology. 2000 Feb;214(2):476-82 [10671596.001]
  • [Cites] Semin Pediatr Surg. 2000 Nov;9(4):209-15 [11112838.001]
  • [Cites] Radiographics. 1992 Jul;12(4):673-86 [1636033.001]
  • [Cites] Radiology. 1987 Oct;165(1):15-8 [3306783.001]
  • [Cites] J Comput Assist Tomogr. 1996 May-Jun;20(3):370-4 [8626892.001]
  • [Cites] Radiology. 1985 Feb;154(2):333-7 [3880903.001]
  • [Cites] Radiographics. 1995 Mar;15(2):301-13 [7761636.001]
  • [Cites] AJR Am J Roentgenol. 1982 Sep;139(3):505-10 [6981314.001]
  • [Cites] Radiology. 1983 May;147(2):491-4 [6836127.001]
  • [Cites] Prenat Diagn. 1997 Mar;17 (3):276-80 [9110373.001]
  • [Cites] Pediatr Surg Int. 2001 Sep;17(7):552-4 [11666059.001]
  • [Cites] Radiographics. 1998 Sep-Oct;18(5):1171-87 [9747614.001]
  • [Cites] AJR Am J Roentgenol. 1994 May;162(5):1091-4 [8165988.001]
  • [Cites] Radiology. 1995 Apr;195(1):196-200 [7892468.001]
  • [Cites] AJR Am J Roentgenol. 1991 Aug;157(2):375-9 [1853825.001]
  • (PMID = 15536562.001).
  • [ISSN] 0301-0449
  • [Journal-full-title] Pediatric radiology
  • [ISO-abbreviation] Pediatr Radiol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 50
  •  go-up   go-down


30. Mathonnet M: [Lymph node dissection in non-medullary differentiated thyroid carcinoma]. Ann Chir; 2006 Jul-Aug;131(6-7):361-8
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Papillary and follicular thyroid carcinomas are the most common form of endocrine carcinomas.
  • [MeSH-major] Adenocarcinoma, Follicular / surgery. Carcinoma, Papillary / surgery. Lymph Node Excision. Thyroid Neoplasms / surgery
  • [MeSH-minor] Adult. Age Factors. Biopsy, Needle. Data Interpretation, Statistical. Female. Humans. Lymph Nodes / pathology. Lymphatic Metastasis / diagnosis. Lymphatic Metastasis / pathology. Male. Middle Aged. Multivariate Analysis. Neck Dissection. Neoplasm Metastasis. Neoplasm Recurrence, Local. Neoplasm Staging. Prognosis. Retrospective Studies. Risk Factors. Sensitivity and Specificity. Sentinel Lymph Node Biopsy. Thyroid Gland / pathology. Thyroidectomy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16329987.001).
  • [ISSN] 0003-3944
  • [Journal-full-title] Annales de chirurgie
  • [ISO-abbreviation] Ann Chir
  • [Language] fre
  • [Publication-type] Comparative Study; English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 52
  •  go-up   go-down


31. Hines OJ, Reber HA: Pancreatic surgery. Curr Opin Gastroenterol; 2009 Sep;25(5):460-5
MedlinePlus Health Information. consumer health - Pancreatic Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RECENT FINDINGS: Obesity is an important risk factor for many diseases of the pancreas, including pancreatic adenocarcinoma.
  • Recent evidence suggests that obese patients with pancreatic cancer appear to have more advanced disease at the time of diagnosis and a worse outcome following resection.
  • Resection of pancreatic endocrine neoplasms is often appropriate, even in the face of metastatic disease.
  • For those dedicated to the study and treatment of this gland, several new advances help the clinician with treatment decisions.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19550315.001).
  • [ISSN] 1531-7056
  • [Journal-full-title] Current opinion in gastroenterology
  • [ISO-abbreviation] Curr. Opin. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 22
  •  go-up   go-down






Advertisement